NMTC

NeuroOne Medical Technologies CorporationNASDAQHealthcare

$0.80+4.39%ClosedMarket Cap: $40.3M

As of 2026-04-06

Valuation

P/E (TTM)

—

PEG

—

P/B

6.52

P/S

4.83

EV/EBITDA

-5.68

DCF Value

$-53.82

FCF Yield

-14.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

54.9%

Operating Margin

-87.7%

Net Margin

-78.3%

ROE

-119.9%

ROA

-79.6%

ROIC

-102.7%

Income Statement

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q1 2026	$2.9M	54.2%	$-1.7M	$-1.4M	$-0.03	—
Q4 2025	$2.7M	55.8%	$-1.4M	$-1.6M	$-0.04	—
FY 2025	$12.1M	67.3%	$-4.2M	$-3.6M	$-0.09	—
Q3 2025	$1.7M	53.9%	$-1.9M	$-1.5M	$-0.03	—
Q2 2025	$1.4M	55.6%	$-2.7M	$-2.3M	$-0.07	—
Q1 2025	$3.3M	58.9%	$1.7M	$1.8M	$0.06	—
Q4 2024	$272.3K	51.8%	$-2.8M	$-3.4M	$0.34	—
FY 2024	$3.5M	31.3%	$-11.9M	$-12.3M	$-0.46	—
Q3 2024	$825.8K	34.1%	$-2.8M	$-2.8M	$-0.10	—
Q2 2024	$1.4M	28.3%	$-2.9M	$-2.9M	$-0.11	—
Q1 2024	$977.6K	27.2%	$-3.4M	$-3.3M	$-0.14	—
Q4 2023	$741.8K	26.1%	$-3.2M	$-3.1M	$-0.13	—